Orofacial dyskinesia and senile dementia of the Alzheimer type
โ Scribed by V. O'Keane; Dr. Timothy G. Dinan
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 314 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0885-6230
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
We evaluated 14 patients with senile dementia of Alzheimer type (SDAT) and 15 age-matched normal elderly controls using psychological tests and computed tomography scans. The low-density rate (LDR) was used as an index of brain atrophy. SDAT patients had significantly higher scores on the Hasegawa D
Milacemide, both an MAO-B inhibitor and a prodrug for glycine, has demonstrated cognitive enhancing effects in animal models, in cognitively intact young and elderly, and has been suggested as a potential treatment for senile dementia of the Alzheimer type (SDAT). This multicenter open-label trial e
Objective. The main hypothesis was that subtle vitamin B12 deยฎciencies occur more commonly in senile dementia of Alzheimer type (SDAT) than in healthy elderly individuals, and may be revealed by elevated total serum homocysteine (tHcy). A subsidiary hypothesis was that such deยฎciencies would be nutr